NEW APPROACH IN URTICARIA TREATMENT
The article presents the European Guidelines for the Diagnostics and Management of Urticaria (revised in 2013) and new data on the physiopathology of urticaria related to the role of the platelet-activating factor (PAF) activating mast cells, attracting eosinophils and neutrophils, improving vascula...
Main Author: | A. V. Samtsov |
---|---|
Format: | Article |
Language: | English |
Published: |
State Scientific Center of Dermatovenereology and Cosmetology
2017-08-01
|
Series: | Vestnik Dermatologii i Venerologii |
Subjects: | |
Online Access: | https://www.vestnikdv.ru/jour/article/view/95 |
Similar Items
-
The benefit of H2 receptors antagonist Rupatadine in treatment for urticaria
by: A. A. Kubanov, et al.
Published: (2017-08-01) -
Comparison of efficacy, safety and cost-effectiveness of rupatadine and olopatadine in patients of chronic spontaneous urticaria: A randomized, double-blind, comparative, parallel group trial
by: Ganesh N Dakhale, et al.
Published: (2016-01-01) -
Efficacy of increased dose of rupatadine up to 20 mg on itching in Japanese patients due to chronic spontaneous urticaria, dermatitis, or pruritus: A post hoc analysis of phase III clinical trial
by: Michihiro Hide, et al.
Published: (2019-10-01) -
Urticaria in children: pathogenetic mechanisms and the possibilities of modern therapy
by: A. V. Kudryavceva, et al.
Published: (2017-08-01) -
Features of adaptive immunity in children with moderate acute urticaria
by: S. V. Maltsev, et al.
Published: (2019-12-01)